Finnrick - Ensuring a Safer and More Transparent Supply Chain
Kangshengda Technology

Kangshengda Technology

Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP agonist) from Kangshengda Technology between 12 Jun 2026 and 22 Jul 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).

Finnrick Rating™
Tentative Rating
Kangshengda Technology
Tirzepatide
Tested 5 Samples
Last test 22 Jul 2026

Take Action

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Kangshengda Technology

Samples are tested in commercial labs

Tests Count

5

Scores

AVG7.0MIN0.0MAX10.0

Last

22 Jul 2026

First

12 Jun 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
22 Jul 2026View8.510mg8.98mg-10.2%99.90%n/a2026-04-TR10No label / Silver crimp / Pink capLab EPublic
26 Jun 2026View10.040mg40.5mg+1.3%99.90%n/a04/21/2026No label / Silver crimp / Pink capLab EPublic
26 Jun 2026View10.020mg20.4mg+2.0%99.90%n/a04/21/2026No label / Silver crimp / Pink capLab EPublic
15 Jun 2026View0.010mg
⚠️ Sample does not contain Tirzepatide
below LOQ
(no batch ID)White label / Silver crimp / Pink capLab EPublic
12 Jun 2026View6.730mg25mg-16.7%99.60%n/a03/26/2026No label / Silver crimp / Blue capLab GPublic
Test my peptides for free